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Calmodulin-dependent multiprotein kinase and protein kinase C phosphorylate and inactivate both intact, microsomal HMG-CoA reductase, and 
the purified 53 kDa catalytic fragment. Isolation of the single phosphopeptide produced by combined cleavage with cyanogen bromide and Lys-C 
proteinase reveals that this is due to phosphorylation of a single serine residue near the C-terminus, corresponding to serine-872 in the human 
enzyme. This is identical with the single serine phosphorylated by the AMP-activated protein kinase. The nature of the protein kinase responsible 
for phosphorylation of this site in vivo is discussed. 
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1. INTRODUCTION 
The principal regulatory step in the biosynthetic 
pathway of cholesterol and other isoprenoid com- 
pounds, the conversion of HMG-CoA to mevalonate, is 
catalysed by HMG-CoA reductase [l]. This enzyme is 
subject to complex multivalent control mechanisms [2], 
including acute regulation of the activity of the enzyme 
by reversible phosphorylation [ 11. Several protein 
kinases phosphorylate and inactivate HMG-CoA reduc- 
tase in vitro, including the AMP-activated protein 
kinase (formerly termed HMG-CoA reductase kinase), 
which is itself activated allosterically by 5’-AMP, and 
by phosphorylation by a distinct kinase [3-51. The 
AMP-activated protein kinase is the major Ca’+-in- 
dependent HMG-CoA reductase kinase in rat liver and 
may have a general role in the regulation of lipid 
metabolism [4]. Recently we have demonstrated that 
the AMP-activated protein kinase phosphorylates a 
single site on HMG-CoA reductase (corresponding to 
serine-872 in the human enzyme). This site is highly 
phosphorylated in intact rat liver under conditions 
where HMG-CoA reductase is largely in the inactive 
form [6]. HMG-CoA reductase is also phosphorylated 
by protein kinase C [7] and two calmodulin-dependent 
protein kinases from rat brain 181. One of the latter was 
apparently identical with calmodulin-dependent multi- 
protein kinase (calmodulin-dependent protein kinase II) 
[9], while the other appeared to be a low molecular 
weight isoform with a different &subunit [8]. In this 
study we show that protein kinase C and calmodulin- 
dependent multiprotein kinase phosphorylate and in- 
activate HMG-CoA reductase by phosphorylation at 
the same single site phosphorylated by the AMP-acti- 
vated protein kinase. 
2. MATERIALS AND METHODS 
2.1. Materials 
Calmodulin-dependent multiprotein kinase was purified from rat 
brain [IO]. Calmodulin purified from sheep brain (1 I], glycogen syn- 
thase purified from rabbit skeletal muscle [12] and the catalytic 
subunit of protein phosphatase 2A purified from rabbit skeletal mus- 
cle [13] were provided by Mr Barry Caudwell Dr Julie Pitcher and Mr 
Don Schelling respectively in this department. Protein kinase C (mix- 
ture of rat brain isozymes) was donated by Dr Peter Parker, Ludwig 
Institute, London and Dr Alastair Aitken, National Institute for 
Medical Research, London. The catalytic fragment and intact forms 
of HMG-CoA reductase were prepared from rats fed diets containing 
cholestyramine and mevinolin [4,6]. Phosphatidylserine was from 
Lipid Products, Surrey, UK. Tetradecanoyl phorbol acetate (TPA) 
and histone Hl (Type HI-S) was from Sigma Chemical Co., Poole, 
UK. Anti-HMG-CoA reductase sera and other materials have been 
described elsewhere [4,6]. 
2.2. Phosphorylation of the catalytic fragment of HMG-CoA 
reductase 
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The catalytic fragment of HMG-CoA reductase (0.1-0.2 mg/ml) 
was phosphorylated at 30°C in incubations which contained 50 mM 
Na MOPS, pH 6.5, 4 mM dithiothreitol, 2.5 mM MgClr, 0.1 mM 
[Y-~*P]ATP (2-5 x 16 cpm/nmol by Cerenkov counting) and either 
calmodulin-dependent multiprotein kinase, 10% (by vol.) glycerol, 
0.01 mg/ml calmodulin and 0.5 mM CaCla, or protein kinase C, 1.25 
mg/ml phosphatidyl serine, 1.25 r&ml TPA, 0.25% (v/v) Triton 
X-100 and 1 mM CaClr. Phosphatidylserine, TPA and Triton X-108 
were added as mixed micelles [ 141. 
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Measurement of inactivation and phosphorylation of HMG-COA 
reductase, and digestion with cyanogen bromide and Lys-C endopro- 
teinase were as described previously [6]. 
2.3. Phosphorylation and immunoprecipitation of the native (100 
kDa) form of HMG-CoA reductase 
To dephosphorylate HMG-CoA reductase and inactivate en- 
dogenous AMP-activated protein kinase, microsomes (20 mg pro- 
tein/ml) were incubated at 30°C in 20 mM Tris HCl, pH 7.2, 2 mM 
EGTA, 2 mM EDTA, 1 mM phenylmethanesulphonylfluoride 
(PMSF), 0.1 mM leupeptin, 4 mM dithiothreitol and the catalytic 
subunit of protein phosphatase 2A. After 15 min, phosphatase activi- 
ty was blocked with the addition of NaF and Na pyrophosphate to 50 
mM and 5 mM respectively, and the microsomes isolated by cen- 
trifugation and resuspended in 50 mM MOPS, pH 6.5, 50 mM NaF, 
5 mM NaPPi, 4 mM dithiothreitol, 1 mM PMSF, 0.1 mM leupeptin. 
Incubation of the microsomes with calmodulin-dependent 
multiprotein kinase or protein kinase C was then carried out at 20 mg 
protein/ml in a reaction volume of 250~1 under the same conditions 
used for phosphorylation of the catalytic fragment, except that 50 
mM NaF, 5 mM NaPPi, 1 mM PMSF and 0.1 mM leupeptin were in- 
cluded in the incubation buffers. The reaction was terminated by the 
addition of EDTA to 17 mM, and intact (100 kDa) HMG-CoA reduc- 
tase was immunoprecipitated and digested as described in [6]. 
2.4. Purification and analysis of phosphopeptides and other ana- 
lytical procedures 
HPLC purification, sequencing, mass spectrometry and isoelectric 
focussing of phosphopeptides were as described previously [6]. Pro- 
tein concentration was measured by the dye-binding method of Brad- 
ford [15]. 
3. RESULTS 
3.1. Phosphorylation and inactivation of HMG-CoA 
reductase by calmodulin-dependent multiprotein 
kinase and protein kinase C 
Calmodulin-dependent multiprotein kinase inac- 
tivated the intact (97 kDa) form of HMG-CoA reduc- 
tase, detergent-solubilized from liver microsomes, and 
this inactivation was totally dependent on the presence 
of calcium and calmodulin. Purified catalytic fragment 
of HMG-CoA reductase (53 kDa) was also inactivated 
with a concomitant incorporation of phosphate 
(Fig. 1). The initial rate of phosphorylation of the 
catalytic fragment was about 25% that of glycogen syn- 
thase, which is one of the better substrates for the 
calmodulin-dependent multiprotein kinase [9] (both 
substrates at 2 ,uM). As reported for the low molecular 
weight calmodulin-dependent protein kinase [8], the 
rate of phosphorylation of the catalytic fragment of 
HMG-CoA reductase at pH 7.2 was 7-fold lower than 
at pH 6.5 (not shown). 
As previously reported [7], protein kinase C inac- 
tivated both the intact microsomal and catalytic frag- 
ment forms of HMG-CoA reductase, although the 
stoichiometry of phosphorylation of the catalytic frag- 
ment was low (co.2 mol/mol) and the initial rate of 
phosphorylation was only 10% of that of histone HI 
(not shown). Cyclic AMP-dependent protein kinase did 
not phosphorylate HMG-CoA reductase significantly 
(not shown). 
214 
20 40 60 
Time (min) 
Fig. 1. Phosphorylation and inactivation of HMG-CoA reductase by 
calmodulin-dependent multiprotein kinase. The top panel shows inac- 
tivation of the detergent-solubilized [4] intact enzyme (100 kDa) in the 
presence (filled circles) and absence (open circles) of Ca’+/cal- 
modulin: results are expressed as a percentage of the activities in a 
control incubation lacking kinase. The bottom panel shows results 
with the soluble 53 kDa fragment of HMG-CoA reductase. Activity 
(filled circles) is expressed as a percentage of the activity of controls 
lacking Caf+/calmodulin; open squares show the Ca’+/calmodu- 
lin-dependent phosphorylation: a small amount of Ca’+/calmodu- 
lin-independent phosphorylation (< 0.05 mol/mol) has been sub- 
3.2. 
tracted. 
Analysis of the site phosphorylated on the cata- 
lytic fragment of HMG-CoA reductase by cal- 
modulin-dependent multiprotein kinase and 
protein kinase C 
Five nmol of the catalytic fragment of HMG-CoA 
reductase was phosphorylated either by calmodulin- 
dependent multiprotein kinase to a stoichiometry of 0.5 
mol phosphate/m01 fragment (producing an inactiva- 
tion of 63% compared to controls lacking kinase), or by 
protein kinase C to a stoichiometry of 0.2 mol phos- 
phate/mol fragment (23% inactivation). Digestion with 
cyanogen bromide and Lys-C endoproteinase and 
analysis by reversed phase HPLC demonstrated that, 
following phosphorylation by either kinase, a single 
phosphopeptide was produced which eluted at -23 
min, on the acetonitrile gradient used, identical to that 
produced after phosphorylation by the AMP-activated 
protein kinase [6] (Fig. 2). The phosphopeptides were 
pure after this single run, and had the amino acid se- 
quence Vr13H~7N57R2rS7K33 (calmodulin-dependent 
protein kinase) and V66H12Nz9R&4Kr5 (protein kinase 
C) [subscripts donate the pmol of phenylthiohydantoin 
derivative detected at each cycle]. In the case of the 
calmodulin-dependent protein kinase, fast atom bom- 
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Fig. 2. Reversed-phase HPLC analysis of cyanogen bromideltys-C 
proteinase peptides derived from the 53 kDa fragment of HMG-CoA 
reductase. after phosphorylation using [y-“P]ATP and three dif- 
ferent protein kinases. The continuous line shows radioactivity 
detected using an on-line monitor. 
bardment-mass spectrometry of the peptide demon- 
strated that the MH+ ion had the expected mass of 820. 
After ethanethiol derivatization of the peptide, which 
converts phosphoserine to the novel, stable amino acid, 
S-ethylcysteine, the phenylthiohydantoin derivative of 
S-ethylcysteine was detected at cycle 5 during sequenc- 
ing, conclusively demonstra~ng that this serine was the 
phosphorylated residue. 
3.3. Analysis of the site phosphorylated on native 
microsomal HMG-CoA reductase 
Incubation of crude microsomes (pre-treated with 
protein phosphatase 2A) with unlabelled ATP and 
either calmodulin-dependent protein kinase or protein 
kinase C produced an inactivation of HMG-CoA reduc- 
tase of 55olo and 30% respectively compared to controls 
incubated without kinase (not shown). HMG-CoA 
reductase was phosphorylated using [y-32P]ATP under 
the same conditions, and then immunopr~ipitated. 
Polyacrylamide gel electrophoresis of the immuno- 
precipitates in sodium dodecyl sulphate showed that in- 
tact (97 kDa) HMG-CoA reductase was the only 32P- 
labelled polypeptide in the precipitate following phos- 
phorylation by either kinase. Digestion with cyanogen 
bromide and Lys-C endoproteinase produced a single 
phosphopeptide which comigrated on isoelectric focus- 
sing with the VHNRSK peptide produced following 
phosphorylation of the catalytic fragment (Fig. 3), con- 
Cai~odu~in- 
dependent Protein 
Fig. 3. Isoelectric focussing of cyanogen bromide/Lys-C proteinase 
peptides derived from HMG-CoA reductase which had been 
phosphorylated using [r-“P]ATP and calmodulin-dependent 
multiprotein kinase or protein kinase C. The photograph shows an 
autoradiogram of the dried gel, with the pH scale being estimated us- 
ing coloured marker proteins (BDH). HMO-CoA reductase was either 
phosphoryiated in microsomes and isolated using immunopr~ipita- 
tion (100 kDa), or the catalytic fragment was purified to homogeneity 
and then phosphorylated (53 kDa). ‘Peptide’ represents the VHNRSK 
peptide purified as for the upper panel of Fig. 2. 
firming that this is the only site on intact HMG-CoA 
reductase phosphorylated by c~modulin-dependent 
multiprotein kinase or protein kinase C. 
4. DISCUSSION 
In this study we have established that calmodulin- 
dependent multiprotein kinase and protein kinase C in- 
activate HMG-CoA reductase via phosphorylation of 
the same single site that is phosphorylated by the AMP- 
activated protein kinase. This regulatory site, which 
corresponds to serine-872 in the human sequence 161, is 
located close to the C-terminus of HMG-CoA reduc- 
tase, and the primary sequence of this region in the rat 
enzyme is shown in Fig. 4. We have suggested that 
recognition by the AMP-activated protein kinase may 
require hydrophobic residues on either side of the 
phosphorylated serine residue, which may be located on 
a P-turn 161. Sites phosphorylat~ by calmod~in- 
dependent multiprotein kinase normally have an 
arginine on the N-terminal side (at - 3) of the phos- 
phorylated residue [9, Fig. 41. In the case of HMG-CoA 
reductase the residue at - 3 is a histidine, although 
there is an arginine residue at - 1. It is possible that 
histidine can replace arginine in the recognition site as 
long as it carries a positive charge. This might explain 
the higher rate of phosphorylation of HMG-CoA 
reductase at pH 6.5 compared with pH 7.2. Protein 
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Synapsin-1 (site 2) : -Ala-Thr-BLg-Gln-Ala-Ser-Ile-Ser-Gly- 
Synapsin-1 (site 3): -Pro-Ile-~-Gln-Ala-Ser-Gln-Ala-Gly- 
Glycogen synthase: -Leu-Ser-BLp-Thr-Leu-Ser-Val-Ser-Ser- 
Tyrosine hydroxylase: -Phe-&-BIp-Ala-Val-Ser-Glu-Gln-Asp- 
Cardiac phospholamban: -Ile-a-~-Ala-Ser-Thr-Ile-Glu-Met- 
P/P' autophosphorylation site: -Met-&-&&-Gln-Glu-Thr-Val-Glu-Cys- 
HMG-CoA reductase: -Met-Val-&j-Asn-&-Ser-Ycn_Ile-Asn- 
interleukin-2 receptor: -A&-u-Glu-&&-a-Ser-86p-&&-Thr- 
EGP receptor: -fle-Val-&&&-J&i&-&&&-Thr-Leu-J&&-m- 
80 kDa protein (1): -u-m-m-Elb;a-Phe-Ser-Phe-u-m- 
80 kDa protein (21: -Phe-Ser-Phe-J@-hXg-Ser-Phe-u-Leu- 
80 kDa protein (3): -a-Ser-Phe-Q&-Leu-Ser-Gly-Phe-Ser- 
80 kDa protein (4): -&-Leu-Ser-Gly-Phe-Ser-Phe-u-m- 
Fig. 4. Comparison of the sequence around the site phospho~lated on HMG-CoA reductase with those on other substrates for c~modulin- 
dependent multiprotein kinase (top) and protein kinase C (bottom). Basic residues, in&ding histidine, are underlined; phosphorylated 
serine/threonine residues are marked with an arrow and bold type. 
kinase C prefers sites that have one or more basic 
residues (arginine or lysine) on the N- and C-terminal 
side of the phosphorylated residue f16, Fig. 41, and in 
HMG-CoA reductase this is satisfied by an arginine at 
- 1 and lysine at + 1. Cyclic AMP-dependent protein 
kinase, which does not phosphorylate HMG-CoA 
reductase significantly, has a minimum requirement for 
an arginine at - 2f - 3 [ 171, not found at this site. 
We have demonstrated recently that HMG-CoA 
reductase is almost completely inactivated and highly 
phosphorylated at the C-terminal site (corresponding to 
serine-872 in the human enzyme) when rats are killed 
and the livers removed by dissection. Under these con- 
ditions, it is likely that the AMP-activated protein 
kinase is responsible for phosphorylation of HMG- 
CoA reductase [6]. However, phosphorylation and in- 
activation by three protein kinases in vitro means that 
HMG-CoA reductase, and hence cholesterol and iso- 
prenoid biosynthesis, can potentially be regulated by 
diverse signals in vivo. Since the three protein kinases 
phosphorylate the same site, we cannot establish by site 
analysis which is responsible for phosphorylation in 
vivo. One approach to examine whether calmodulin- 
dependent multiprotein kinase and/or protein kinase C 
might be physiological regulators is to stimulate these 
kinases ph~macologically in isolated cells and examine 
the effect on phosphorylation of HMG-CoA reductase. 
In isolated hepatocytes, phorbol esters or synthetic 
diacylglycerols which activate protein kinase C do not 
cause inactivation of HMG-COA reductase (V.A. Zam- 
mit and A. Caldwell, personal communication). 
Although hormones or ionophores which elevate in- 
tracellular calcium do cause inactivation [ 18 1, this is not 
blocked by calmodulin antagonists (V.A.Z. and A.C., 
personal communication). These results would argue 
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against a role for protein kinase C or calmodulin- 
dependent protein kinases in the regulation of HMG- 
CoA reductase in these cells. However, now that the 
location of the site of phosphorylation has been iden- 
tified, it will be possible to examine the effects of these 
agents on phosphorylation of HMG-CoA reductase 
more directly. 
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